|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 307/935 |
| (11) | Number of the document | 2864308 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13736609.2 |
| Date of filing the European patent application | 2013-06-11 | |
| (97) | Date of publication of the European application | 2015-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2013/051532 |
| Date | 2013-06-11 |
| (87) | Number | WO 2013/186550 |
| Date | 2013-12-19 |
| (30) | Number | Date | Country code |
| 201210235 | 2012-06-11 | GB |
| (72) |
AGGARWAL, Varinder, Kumar, GB
COULTHARD, Mark, Graeme, GB
ERB, William, FR
|
| (73) |
University Of Bristol,
Senate House Tyndall Avenue Clifton, Bristol BS8 1TH,
GB
|
| (54) | (3aR,6aS)-2-Hydroxy-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-5-carbaldehyde intermediates for the preparation of prostaglandins or prostaglandin analogues |
| (3aR,6aS)-2-Hydroxy-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-5-carbaldehyde intermediates for the preparation of prostaglandins or prostaglandin analogues |